THMO (ThermoGenesis Holdings) OCF Yield %: -180,550.00 (As of Jul. 01, 2026)


THMO ThermoGenesis Holdings Inc THMO
16 GF Score
Price $0.00
View Full Analysis

What is ThermoGenesis Holdings OCF Yield %?

ThermoGenesis Holdings THMO 16 OCF Yield % is -180,550.00 as of Jul. 01, 2026. GuruFocus rates THMO with a GF Score™ of 16/100.

OCF Yield % is calculated as Cash Flow from Operations divided by Market Capitalization. It is a financial solvency ratio that compares the operating cash flow a company is expected to earn against its market value.

As of today, ThermoGenesis Holdings's Trailing 12-Month Cash Flow from Operations is $-3.61 Mil, and Market Cap is $0.00 Mil. Therefore, ThermoGenesis Holdings's OCF Yield % for today is -180,550.00%.

The historical rank and industry rank for ThermoGenesis Holdings's OCF Yield % or its related term are showing as below:

THMO' s OCF Yield % Range Over the Past 10 Years
Min: -8742300   Med: 0   Max: 454400
Current: -180550


During the past 13 years, the highest OCF Yield % of ThermoGenesis Holdings was 454400.00%. The lowest was -8742300.00%. And the median was %.

THMO's OCF Yield % is not ranked
in the Medical Devices & Instruments industry.
Industry Median: 1.79 vs THMO: -180550.00

ThermoGenesis Holdings's OCF Margin % for the quarter that ended in Mar. 2024 was %.


ThermoGenesis Holdings OCF Yield % Explanation

Similar to Earnings Yield %, OCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high operating cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.


ThermoGenesis Holdings OCF Yield % Related Terms


ThermoGenesis Holdings OCF Yield % Historical Data

* Premium members only.

The historical data trend for ThermoGenesis Holdings's OCF Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

ThermoGenesis Holdings OCF Yield % Chart

ThermoGenesis Holdings Annual Data
Trend Jun14 Jun15 Jun16 Jun17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
OCF Yield %
Get a 7-Day Free Trial Premium Member Only Premium Member Only -26.13 -76.90 -54.96 -219.47 -171.13

ThermoGenesis Holdings Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
OCF Yield % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -61.13 -102.24 -23.19 -375.82 -35.57

THMO vs MSIU, MOTS, ABT: OCF Yield % Comparison

For the Medical Devices subindustry, ThermoGenesis Holdings's OCF Yield %, along with its competitors' market caps and OCF Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


ThermoGenesis Holdings OCF Yield % vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, ThermoGenesis Holdings's OCF Yield % distribution charts can be found below:

* The bar in red indicates where ThermoGenesis Holdings's OCF Yield % falls into.


THMO
16GF Score
ThermoGenesis Holdings Inc THMO
OCF Yield % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

ThermoGenesis Holdings OCF Yield % Calculation

OCF Yield % is a financial solvency ratio that compares the operating cash flow a company is expected to earn against its market value.

ThermoGenesis Holdings's OCF Yield % for the fiscal year that ended in Dec. 2023 is calculated as

OCF Yield %=Cash Flow from Operations / Market Cap
=-3.721 / 2.174418
=-171.13%

ThermoGenesis Holdings's annualized OCF Yield % for the quarter that ended in Mar. 2024 is calculated as

OCF Yield %=Cash Flow from Operations * Annualized Factor / Market Cap
=-0.505 * 4 / 5.678442
=-35.57%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about OCF Yield % →
What does a OCF Yield % of -180,550.00 mean?
ThermoGenesis Holdings (THMO) has a OCF Yield % of -180,550.00 as of Jul. 01, 2026. OCF Yield is calculated as Cash Flow from Operations divided by Market Capitalization. View historical data on ThermoGenesis Holdings and its competitors.
Is ThermoGenesis Holdings' OCF Yield % too high?
ThermoGenesis Holdings' current OCF Yield % is -180,550.00. Overall, ThermoGenesis Holdings has a GF Score™ of 16/100, reflecting its overall financial health beyond just this single metric.
How does ThermoGenesis Holdings' OCF Yield % compare to MSIU and MOTS?
ThermoGenesis Holdings' OCF Yield % of -180,550.00 can be compared against companies in the Medical Devices & Instruments industry. The industry median OCF Yield % is 1.79. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good OCF Yield % for a Medical Devices & Instruments company?
The median OCF Yield % among Medical Devices & Instruments companies is 1.79, based on 851 companies in the industry. Companies in the top quartile (top 25%) have a OCF Yield % significantly above this median, while those in the bottom quartile fall well below. However, OCF Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high OCF Yield % mean?
A high OCF Yield % can signal that a stock is expensive relative to its fundamentals. OCF Yield is calculated as Cash Flow from Operations divided by Market Capitalization. View historical data on ThermoGenesis Holdings and its competitors. For the Medical Devices & Instruments industry, the median OCF Yield % is 1.79 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. ThermoGenesis Holdings's current OCF Yield % is -180,550.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is ThermoGenesis Holdings stock overvalued right now?
ThermoGenesis Holdings (THMO) has a current OCF Yield % of -180,550.00. The current OCF Yield % is -180,550.00. ThermoGenesis Holdings' overall GF Score™ is 16/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is OCF Yield % calculated?
OCF Yield % is calculated from a company's financial statements. For ThermoGenesis Holdings (THMO), the current OCF Yield % is -180,550.00 as of Jul. 01, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

ThermoGenesis Holdings Business Description

Address 2711 Citrus Road, Rancho Cordova, CA, USA, 95742
ThermoGenesis Holdings Inc develops, commercializes and markets a range of automated technologies for CAR-T and other cell-based therapies. The company markets a full suite of solutions for automated clinical biobanking, point-of-care applications, and automation for immuno-oncology, including its semi-automated, functionally-closed CAR-TXpress platform, which streamlines the manufacturing process for the emerging CAR-T immunotherapy market. It offers the AutoXpress and BioArchive platforms for automated clinical bio-banking, PXP platform for point-of-care cell-based therapies and CAR-TXpress platform for bio-manufacturing for immuno-oncology applications.
16GF Score

Get the complete analysis for THMO

OCF Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.00
Price